Knocking out MeCP2 in inhibitory neurons causes symptom-specific effects, suggesting a substantial role for GABA-ergic dysregulation in Rett syndrome (Ito-Ishida et al., 2015). This evidence concerns the gene MECP2 and atypical Rett syndrome.